{"entity":{"id":"nct06122584","kind":"trial","name":"Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer","aka":[],"tldr":"A phase 3 trial of PSMA-1007 F-18 run by ABX advanced biochemical compounds GmbH in prostate cancer, now recruiting.","summary":"Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer is a phase 3 interventional study registered as NCT06122584 by ABX advanced biochemical compounds GmbH, with 380 participants planned, started 2024-06-13. Conditions listed: Prostate Cancer. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06122584","url":"https://clinicaltrials.gov/study/NCT06122584"}],"tags":["ctgov-ingest"],"related":[],"cancers":["prostate","prostate-high-risk"],"sections":[],"technologies":[],"targets":[],"drugs":["psma-1007-f18"],"companies":["abx-advanced-biochemical-compounds"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06122584","phase":"3","setting":"Prospective, Multi-Center Study to Assess the Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed High-Risk or Very-High-Risk Prostate Cancer","sponsor":"ABX advanced biochemical compounds GmbH","participation":[{"nct":"NCT06122584","source":"https://clinicaltrials.gov/study/NCT06122584","fetchedAt":"2026-10-07T16:54:14.819Z","studySha256":"f66619a10b8c84695cd270ce283c4669daecd9a676033cac450e4c189e6f40e5","overallStatus":"RECRUITING","lastUpdatePosted":"2026-04-14","leadSponsor":"ABX advanced biochemical compounds GmbH","collaboratorCount":0,"minimumAge":"18 Years","sex":"MALE","healthyVolunteers":false,"hasEligibility":true,"enrolment":380,"enrolmentType":"ESTIMATED","siteCount":18,"recruitingSiteCount":16,"countries":["France","Germany","Italy","Japan","Netherlands","Spain"]}],"started":"2024-06-13","startedType":"actual","enrolled":380,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06122584/","neighbours":{"cancer":[{"id":"prostate-high-risk","kind":"cancer","name":"Localised prostate cancer, high and very high risk","route":"/cancers/prostate-high-risk/"},{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"drug":[{"id":"psma-1007-f18","kind":"drug","name":"PSMA-1007 F-18","route":"/drugs/psma-1007-f18/"}],"company":[{"id":"abx-advanced-biochemical-compounds","kind":"company","name":"ABX advanced biochemical compounds","route":"/companies/abx-advanced-biochemical-compounds/"}]}}